WHAT IS INEFFECTIVE ERYTHROPOIESIS IN MYELODYSPLASTIC SYNDROMES

被引:15
作者
BOWEN, D
机构
[1] Department of Hematology, University of Wales College of Medicine, Cardiff CF4 4XlV, Health Park
关键词
INEFFECTIVE ERYTHROPOIESIS; MYELODYSPLASTIC SYNDROMES;
D O I
10.3109/10428199509059614
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The anaemia of MDS is multifactorial with intramedullary ineffective erythropoiesis resulting from an imbalance between erythroid proliferation, differentiation and apoptosis in favour of initial hypercellularity with high cell death through to a lower cellularity, lower death state with the eventual evolution of the leukaemic clone in many patients. The fundamental molecular abnormality(ies) in MDS, which produce the milieu for the heterogeneous molecular insults described (e.g., oncogene mutations) remains elusive, Many questions such as why MDS red cells are macrocytic and what are the precise cellular and molecular mechanisms of ineffective erythropoiesis remain unanswered but future study of the erythroid lineage should provide molecular clues to the earliest abnormalities in the pathogenesis of MDS.
引用
收藏
页码:243 / 247
页数:5
相关论文
共 43 条
  • [1] May S.J., Smith S.A., Jacobs A., Williams A., Bailey-Wood R., The myelodysplastic syndrome: analysis of laboratory characteristics in relation to the FAB classification, Br. J. Haematol., 59, pp. 311-319, (1985)
  • [2] Mufti G.J., Gal ton D.A.G., Myelodysplastic syndromes: Natural history and features of prognostic importance, Myelodysplastic syndromes, pp. 953-972, (1986)
  • [3] Glinsmann-Gibson B., Spier C., Baier M., Taetle R., Broudy V.C., List A.F., Mast cell growth factor (c-kit ligand) restores growth of multipotent progenitors in myelodysplastic syndromes, Leukaemia, 8, pp. 827-832, (1994)
  • [4] Coutinho L.H., Geary C.G., Chang J., Harrison C., Testa N.G., Functional studies of bone marrow haemopoietic and stromal cells in the myelodysplastic syndromes (MDS), Br. J. Haematol., 75, pp. 16-25, (1990)
  • [5] Milner G.R., Testa N.G., Geary C.G., Dexter T.M., Muldal S., Maclver J.E., Lajtha L.G., Bone marrow culture studies in refractory cytopoenia and smouldering leukaemia, Br. J. Haematol., 35, pp. 251-261, (1977)
  • [6] Oscier D., Worsley A., Darlow S., Figes A., Williams J.D., Hamblin T.J., Correlation of bone marrow colony growth in the myelodysplastic syndromes with the FAB classification and the Bournemouth score, Leuk. Rex, 13, pp. 833-839, (1989)
  • [7] Yoshida Y., Yoshida C., Tohyama K., Ohmori S., Ueda Y., Taniguchi Y., Uchino H., Prognosis implication of sequential bone marrow cultures in the myelodysplastic syndromes, Leuk. Rex, 13, pp. 67-972, (1989)
  • [8] Merchav S., Nielsen O.J., Rosenbaum H., Sharon R., Brenner B., Tatarsky I., Scigalla P., Wieczorek L., In vitro studies of erythropoietin-dependent regulation of erythropoiesis in myelodysplastic syndromes, Leukaemia, 4, pp. 771-774, (1990)
  • [9] Sawada K., Sato N., Tarumi T., Sakai N., Koizumi K., Sakurama S., Leko M., Yasoukouchi T., Koyanagawa Y., Yamaguchi M., Ohmoto A., Kohno M., Koike T., Proliferation and differentiation of myelodysplastic CD34+ cells in serum free medium
  • [10] respponse to individual colony-stimulating factors, Br. J. Haematol., 83, pp. 349-358, (1993)